the effects of an injected placebo on endurance running performance presentation 2
TRANSCRIPT
The Effects of an Injected Placebo on Endurance Running PerformanceRamzy Ross, Cindy M. Gray and Jason M. R. Gill
Terminology
Recombinant Human
Erythropoietin (r-HuEpo)
Hematocrit
Placebo
Background• The placebo effect is acknowledged as a key factor in medical research and,
as a consequence, its effect has been controlled in clinical trials for over 50 years
• The placebo effect has also been recognized in the context of sports performance, with a number of studies reporting statistically significant improvements in endurance, sprint or strength performance with placebo interventions
• Orally administered placebos have been typically shown to improve endurance performance by ~2% in participants who are at least moderately well-trained
Background• Previous studies have assessed performance using either cycle ergometer or
running time-trial performance assessments • Such tests were performed on individual performing alone, and unaware of the
performances of others, rather than assessment during head-to-head field-based competition scenarios
• It’s known that performance is often improved in head-to-head competition settings, compared to settings without a competitive element
• Motivational Intensity Theory predicts that maximum exercise tolerance will be increased when either perception of effort is reduced or ‘potential motivation’ (i.e. the greatest effort an individual is prepared to exert) is increased.
Effects and Benefits of Competition
• Consistent with increased potential motivation, there is evidence that competition results in the following:
• Increased:• Potential motivation• Allocation of effort to an exercise task• Positive emotions• Heart rate• Peak oxygen uptake• Enhanced sympatho-adrenal system activation
• Reduced:• Internal attentional focus
Recombinant Human Erythropoietin (r-HuEpo)
Stimulates renal erythrocyte production
r-HuEpo administration increases hematocrit (Hct)
A key feature of r-HuEpo administration is that it is given
by injection.
Studies on the effects of r-HuEpo administration on
sporting performance in field-based tests are limited, and no study has assessed its effects on performance in a placebo-
controlled trial using field-based head-to-head competition setting.
Recombinant Human Erythropoietin (r-HuEpo)
Aim• To quantify the placebo effect magnitude on endurance running
performance, in ‘real-world’ field-based head-to-head competition settings, of an injected placebo (‘OxyRBX’) purporting to have similar effects to recombinant human erythropoietin (r-HuEPO).
Methods
Methods
Preliminary Study Brief
3 km Races
Data Collection
Quantitative and
Qualitative Data Analysis
Participants
Methods
Methods
Preliminary Study Brief
3 km Races
Data Collection
Quantitative and
Qualitative Data Analysis
Participants
Methods
Methods
Preliminary Study Brief
3 km Races
Data Collection
Quantitative and
Qualitative Data Analysis
Participants
Methods
Methods
Preliminary Study Brief
3 km Races
Data Collection
Quantitative and
Qualitative Data Analysis
Participants
Methods
Methods
Preliminary Study Brief
3 km Races
Data Collection
Quantitative and
Qualitative Data Analysis
Participants
Experimental Design
Quantitative Results
Ross et al. 2014
Quantitative ResultsFigure 3
Ross et al. 2014
Quantitative ResultsFigure 4
Ross et al. 2014
Quantitative Results
Ross et al. 2014
Quantitative Results
Ross et al. 2014
Quantitative Results
Ross et al. 2014
Quantitative Results
Ross et al. 2014
Quantitative Results
Ross et al. 2014
Qualitative Results• Reduction in perceived physical effort
both during training and the competitive races was also evident in the post-study interviews, where some participants described how ‘taking OxyRBX’ had increased their enjoyment of training sessions
• Another noticeable physical effect that many participants experienced during the placebo week (including those whose race times showed no improvement) was enhanced recovery both following training sessions and after the races
• Many participants also described enhanced potential motivation, particularly during the competitive races.
• Almost all of the participants reported that they thought they were taking a real performance enhancing substance during the study, providing further evidence that the briefing procedures used were highly effective in inducing participants’ beliefs that the substance would enhance their performance.
• A few participants reported minor
negative effects (changing sleep patterns, slight pain at the injection site, nausea), almost all mentioned at least some positive effects
Conclusion
The study provided novel insights into the effects of
an injected placebo (OxyRBX), purporting to be
performance enhancing agent similar to r-HuEPO, on endurance performance in a
head-to-head competitive setting.
Further study is needed to determine whether the magnitude of the
placebo effect is similar in athletes at the elite
level
The magnitude of benefit, at 1.2%, is of
clear sporting relevance, but is substantially smaller than the
performance improvement elicited by r-HuEPO administration.
Take Home Messages
Placebo improves competitive
performance by both reducing perception of effort and increasing potential motivation,
in accord with the psychobiological
model for exercise performance
The benefits elicited by a placebo are of
clear sporting relevance
Further study is needed to determine
whether the magnitude of the placebo effect is
similar in athletes at the elite level
Ask and You shall Receive